Roberta Buono

机构：University of California, Irvine, Irvine University · ORCID：0000-0002-0033-5375

发表论文 149 篇 · 总被引 1674 次 · h-index 15

代表论文

• Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response (2025 · Leukemia · 被引 11)
• A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy (2024 · Blood Neoplasia · 被引 9)
• A kidney-specific fasting-mimicking diet induces podocyte reprogramming and restores renal function in glomerulopathy (2024 · Science Translational Medicine · 被引 7)
• Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Pitavastatin counteracts venetoclax resistance mechanisms including TP53 mutation in acute myeloid leukemia (2026 · Blood Neoplasia)
• IP15-12 A KIDNEY SPECIFIC FASTING-MIMICKING DIET INDUCES PODOCYTE REPROGRAMMING AND RESTORES RENAL FUNCTION IN GLOMERULOPATHY (2025 · The Journal of Urology)